| Dr Henry Andrew Irvine, MD | |
|
63245 Silvis Rd, Bend, OR 97701-9743 | |
| (458) 206-0145 | |
| Not Available |
| Full Name | Dr Henry Andrew Irvine |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 22 Years |
| Location | 63245 Silvis Rd, Bend, Oregon |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780663609 | NPI | - | NPPES |
| 127605 | Other | FL | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | 0101235094 (Virginia) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 0101235094 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hurley Medical Center | Flint, MI | Hospital |
| Carolina East Medical Center | New bern, NC | Hospital |
| Onslow Memorial Hospital | Jacksonville, NC | Hospital |
| Southeastern Regional Medical Center | Lumberton, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greensboro Radiology Pa | 8729074901 | 207 |
| Hurley Medical Center | 2961308481 | 264 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Radadvantage A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376719666 PECOS PAC ID: 2163597899 Enrollment ID: O20101115001107 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Brfhh Monroe Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811324882 PECOS PAC ID: 0042446577 Enrollment ID: O20141021002180 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Associated Radiologists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215931290 PECOS PAC ID: 8123009941 Enrollment ID: O20180219001005 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20180426002520 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Desert Advanced Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568416147 PECOS PAC ID: 6406749613 Enrollment ID: O20180529002772 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Pronet Imaging Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528099488 PECOS PAC ID: 5890722755 Enrollment ID: O20190220000066 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Greensboro Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821035999 PECOS PAC ID: 8729074901 Enrollment ID: O20200814000438 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Entity Name | Radiology Affiliates Of Central New Jersey P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811994791 PECOS PAC ID: 1759277239 Enrollment ID: O20210810000772 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Henry Andrew Irvine, MD 63245 Silvis Rd, Bend, OR 97701-9743 Ph: (458) 206-0145 | Dr Henry Andrew Irvine, MD 63245 Silvis Rd, Bend, OR 97701-9743 Ph: (458) 206-0145 |
News Archive
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
Use of cannabinoids (marijuana) could assist in the treatment of post-traumatic stress disorder patients. This is exposed in a recent study carried out at the Learning and Memory Lab in the University of Haifa's Department of Psychology.
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Although more than 425,000 women suffer from stroke each year, 55,000 more than men, a new survey showed that women may be dramatically underestimating their risk of this medical emergency, the third leading cause of death in the United States. Only 27 percent of women who were surveyed could name more than two of the six primary stroke symptoms. Moreover, seven out of 10 women who were surveyed said they are not aware they are more likely than men to have a stroke, and were not at all or only somewhat knowledgeable about risk factors.
America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.
› Verified 9 days ago
Dr. Nicholas Song Boehling, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-5800 Fax: 541-706-6341 | |
Dr. Casey George Curran, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Dr. Brant David Wommack, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Ctr Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Richard Rotondi, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2052 Ne 4th St, Bend, OR 97701 Phone: 541-280-2789 | |
Steven Dean Kjobech, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Dr. David Krieves, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-9327 | |
Dr. Theodore Jennermann, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 |